ARTICLE | Company News
Cynvenio Biosystems sales and marketing update
October 21, 2013 7:00 AM UTC
Cynvenio launched worldwide its ClearID monitoring program for early detection of breast cancer recurrence. The program, which uses blood samples that are analyzed at the company's CLIA-certified labo...